Cargando…
Development of multi-epitope peptide-based vaccines against SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a pandemic involving so far more than 22 million infections and 776,157 deaths. Effective vaccines are urgently needed to prevent SARS-CoV-2 infections. No vaccines have yet been approved for licensure by regulatory agencies. Ev...
Autores principales: | Lim, Hui Xuan, Lim, Jianhua, Jazayeri, Seyed Davoud, Poppema, Sibrandes, Poh, Chit Laa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chang Gung University
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527307/ https://www.ncbi.nlm.nih.gov/pubmed/33727051 http://dx.doi.org/10.1016/j.bj.2020.09.005 |
Ejemplares similares
-
Enhancement of Tetravalent Immune Responses to Highly Conserved Epitopes of a Dengue Peptide Vaccine Conjugated to Polystyrene Nanoparticles
por: Chan, Yanqi, et al.
Publicado: (2020) -
Recent advances in delivery of veterinary DNA vaccines against avian pathogens
por: Jazayeri, Seyed Davoud, et al.
Publicado: (2019) -
Nano and Microparticles as Potential Oral Vaccine Carriers and Adjuvants Against Infectious Diseases
por: Jazayeri, Seyed Davoud, et al.
Publicado: (2021) -
Development of Universal Influenza Vaccines Targeting Conserved Viral Proteins
por: Jazayeri, Seyed Davoud, et al.
Publicado: (2019) -
The development of DNA vaccines against SARS-CoV-2
por: Khalid, Kanwal, et al.
Publicado: (2023)